Trepel JB - Search Results

1

Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ, Tofilon PJ. Camphausen K, et al. Among authors: trepel jb. Cancer Res. 2004 Jan 1;64(1):316-21. doi: 10.1158/0008-5472.can-03-2630. Cancer Res. 2004. PMID: 14729640

2

Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.

Johnston PG, Drake JC, Trepel J, Allegra CJ. Johnston PG, et al. Cancer Res. 1992 Aug 15;52(16):4306-12. Cancer Res. 1992. PMID: 1643628

3

Effect of guanine and adenine nucleotides on bombesin-stimulated phospholipase C activity in membranes from Swiss 3T3 and small cell lung carcinoma cells.

Sharoni Y, Viallet J, Trepel JB, Sausville EA. Sharoni Y, et al. Among authors: trepel jb. Cancer Res. 1990 Sep 1;50(17):5257-62. Cancer Res. 1990. PMID: 2167151

4

Taxol induction of p21WAF1 and p53 requires c-raf-1.

Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J, Neckers L. Blagosklonny MV, et al. Cancer Res. 1995 Oct 15;55(20):4623-6. Cancer Res. 1995. PMID: 7553639

5

Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3.

Borner MM, Myers CE, Sartor O, Sei Y, Toko T, Trepel JB, Schneider E. Borner MM, et al. Among authors: trepel jb. Cancer Res. 1995 May 15;55(10):2122-8. Cancer Res. 1995. PMID: 7743512

6

Expression of wild-type p53 during the cell cycle in normal human mammary epithelial cells.

Gudas JM, Oka M, Diella F, Trepel J, Cowan KH. Gudas JM, et al. Cell Growth Differ. 1994 Mar;5(3):295-304. Cell Growth Differ. 1994. PMID: 8018562

7

Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.

Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. Blagosklonny MV, et al. Cancer Res. 1996 Apr 15;56(8):1851-4. Cancer Res. 1996. PMID: 8620503

8

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE. Thibault A, et al. Clin Cancer Res. 1996 Mar;2(3):483-91. Clin Cancer Res. 1996. PMID: 9816194 Clinical Trial.

9

Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines.

Yang HK, Scott FM, Trepel JB, Battey JF, Johnson BE, Kelley MJ. Yang HK, et al. Among authors: trepel jb. Lung Cancer. 1998 Sep;21(3):165-75. doi: 10.1016/s0169-5002(98)00054-3. Lung Cancer. 1998. PMID: 9857994

10

MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.

Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ. Lee BI, et al. Among authors: trepel jb. Cancer Res. 2001 Feb 1;61(3):931-4. Cancer Res. 2001. PMID: 11221885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters